Clinical trial
Intensified Chemotherapy in CRC After Resection of Liver Metastases
NCT00208260 · Institut du Cancer de Montpellier - Val d'Aurelle, Other · Completed
Key facts
| NCT number | NCT00208260 |
|---|---|
| Title | Intensified Chemotherapy in CRC After Resection of Liver Metastases |
| Official title | Randomized Phase II Trial Followed by Phase III Trial With Molecular Biology Study, Comparing a Standard Bi-therapy vs 3 Arms of Intensified Chemotherapy in Patients With Unresectable or Not Optimally Resectable Colorectal Cancer Liver Metastases. |
| Lead sponsor | Institut du Cancer de Montpellier - Val d'Aurelle, Other |
| Collaborators | Pfizer Industry Sanofi Chugai Pharmaceutical |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Liver Metastases, Chemotherapy |
| Intervention type | Drug |
| Interventions | FOLFIRI, FOLFOX-4, FOLFIRI-HD, FOLFOX-7, FOLFIRINOX |
| Enrollment | 124 |
| Start date | Apr 1, 2004 |
| Completion | Aug 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 5, 2026 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: